About: JoAnn V Pinkerton

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: JoAnn V Pinkerton Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

American physician

Attributes	Values
rdf:type	Item
description	طبيبة أمريكية (ar) Ameerika Ühendriikide arst (et) American physician (en) মার্কিন চিকিৎসক (bn) doctoriță americană (ro) metgessa estatunidenca (ca) mjeke amerikane (sq) médecin américaine (fr) médica estadounidense (es) médica estadounidense (gl) американська лікарка (uk) רופאה אמריקאית (he)
rdfs:label	JoAnn V Pinkerton (en) JoAnn V Pinkerton (nl) JoAnn V Pinkerton (sq)
skos:prefLabel	JoAnn V Pinkerton (en) JoAnn V Pinkerton (nl) JoAnn V Pinkerton (sq)
name	JoAnn V Pinkerton (en) JoAnn V Pinkerton (nl) JoAnn V Pinkerton (sq)
instance of	wds:Q96619666-A8FBB1A7-4F71-48B3-8BFB-44CAD650D4BC
instance of	Homo sapiens
occupation	wds:Q96619666-26b140b3-4933-20dc-a3c6-534379050ed6 wds:Q96619666-8a8cc9f0-4741-f33f-83d4-3b58cdcb07cb
sex or gender	wds:Q96619666-6ec87733-42d5-705e-f284-08cb472dd5e0
occupation	physician medical researcher
sex or gender	female organism
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q96619666
is author of	Update on medical and regulatory issues pertaining to compounded and FDA-approved drugs, including hormone therapy Compounded bioidentical hormone therapy: identifying use trends and knowledge gaps among US women. Relief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene/conjugated estrogens: a randomized, controlled trial Postmenopausal hormone therapy: an Endocrine Society scientific statement. Bazedoxifene effects on the reproductive tract in postmenopausal women at risk for osteoporosis Bazedoxifene, a selective estrogen receptor modulator: effects on the endometrium, ovaries, and breast from a randomized controlled trial in osteoporotic postmenopausal women The effect of ultralow-dose transdermal estradiol on urinary incontinence in postmenopausal women End-of-life discussions for the primary care obstetrician/gynecologist Gynecologic Safety of Conjugated Estrogens Plus Bazedoxifene: Pooled Analysis of Five Phase 3 Trials Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline Estrogen agonists/antagonists in combination with estrogen for prevention and treatment of menopause-associated signs and symptoms Vasomotor symptoms in menopause: where we've been and where we're going Long-term efficacy and safety of questionnaire-based initiation of urgency urinary incontinence treatment Advances in the treatment of menopausal symptoms Influence of raloxifene on the efficacy of an estradiol-releasing ring for treating vaginal atrophy in postmenopausal women Breast density changes in a randomized controlled trial evaluating bazedoxifene/conjugated estrogens Perspective on menopausal vasomotor symptoms, CAM, and the SWAN Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms: a 12-week, multicenter, parallel-group, randomized, double-blind, placebo-controlled efficacy trial Maintenance of the efficacy of desvenlafaxine in menopausal vasomotor symptoms: a 1-year randomized controlled trial Endometrial safety: a key hurdle for selective estrogen receptor modulators in development Breast effects of bazedoxifene-conjugated estrogens: a randomized controlled trial Relationship between changes in vasomotor symptoms and changes in menopause-specific quality of life and sleep parameters Changing the conversation about hormone therapy Cervical cancer and human papillomavirus in indigenous Guyanese women. Reproduction in couples who are affected by human immunodeficiency virus: Medical, ethical, and legal considerations Compounded Bioidentical Hormones in Endocrinology Practice: An Endocrine Society Scientific Statement Changing the conversation about hormone therapy Perspectives on the first randomized sham-controlled trial of stellate ganglion block for hot flashes Pharmacological therapy for abnormal uterine bleeding Effects of ospemifene on the female reproductive and urinary tracts: translation from preclinical models into clinical evidence Compounded non-FDA-approved menopausal hormone therapy prescriptions have increased: results of a pharmacy survey Algorithm and mobile app for menopausal symptom management and hormonal/non-hormonal therapy decision making: a clinical decision-support tool from The North American Menopause Society Managing Menopausal Symptoms and Associated Clinical Issues in Breast Cancer Survivors Response to Letter to the Editor: "Global Consensus Position Statement on the Use of Testosterone Therapy for Women" Global Consensus Position Statement on the Use of Testosterone Therapy for Women Treatment of urogenital atrophy with low-dose estradiol: preliminary results Ospemifene for the treatment of postmenopausal vulvar and vaginal atrophy: recommendations for clinical use. Why the product labeling for low-dose vaginal estrogen should be changed Phase 3 randomized controlled study of gastroretentive gabapentin for the treatment of moderate-to-severe hot flashes in menopause What are the concerns about custom-compounded "bioidentical" hormone therapy? Think twice before prescribing custom-compounded bioidentical hormone therapy Reproductive aging, menopause, and health outcomes Conjugated estrogens and bazedoxifene in minority populations: pooled analysis of four phase 3 trials Time to transient and stable reductions in hot flush frequency in postmenopausal women using conjugated estrogens/bazedoxifene Not time to abandon use of local vaginal hormone therapies Overall Safety of Ospemifene in Postmenopausal Women from Placebo-Controlled Phase 2 and 3 Trials The need for evidence-based medicine to be integrated into clinical practice: role of the North American Menopause Society Vaginal atrophy Relationship between changes in vulvar-vaginal atrophy and changes in sexual functioning Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual Health The role of androgens in the treatment of genitourinary syndrome of menopause (GSM) Timing and persistence of effect of conjugated estrogens/bazedoxifene in postmenopausal women Underlying breast cancer risk and menopausal hormone therapy Global Consensus Position Statement on the use of Testosterone Therapy for Women Menopause-specific quality of life across varying menopausal populations with conjugated estrogens/bazedoxifene Low-dose paroxetine (7.5 mg) improves sleep in women with vasomotor symptoms associated with menopause Acceptance of fragile X premutation genetic screening in women with ovarian dysfunction Tissue-selective estrogen complex bazedoxifene and conjugated estrogens for the treatment of menopausal vasomotor symptoms Safety and benefit considerations for menopausal hormone therapy The effects of abuse on health problems in menopausal women. Why Should Clinicians Be Concerned About Prescribing Compounded Hormones for Menopausal Women? Treatment of postmenopausal osteoporosis in a patient with celiac disease Female Sexual Health: Barriers to Optimal Outcomes and a Roadmap for Improved Patient-Clinician Communications Ospemifene's effect on vasomotor symptoms: a post hoc analysis of phase 2 and 3 clinical data Pooled Analysis of the Effects of Conjugated Estrogens/Bazedoxifene on Vasomotor Symptoms in the Selective Estrogens, Menopause, and Response to Therapy Trials Hot flush frequency and severity at baseline as predictors of time to transient and stable treatment success: pooled analysis of two CE/BZA studies Global Consensus Position Statement on the Use of Testosterone Therapy for Women Hormone Therapy for Postmenopausal Women Gamete retrieval in terminal conditions: is it practical? What are the consequences?

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software